Since the NO/cGMP/PDE5 signaling pathway is implicated in the neurobiology of mood disorders, it is possible that sildenafil influences depressive symptoms and the therapeutic potential of antidepressant drugs. This evidence concerns the gene PDE5A and mood disorder.